MSFT
40
-3
HRB
41
3
OXY
38
-2
DTE
38
-2
IVZ
68
-5
GD
57
-6
MDLZ
22
-16
CA
21
-6
NTRS
64
-3
HIG
56
-2
AA
67
-5
FSLR
55
-11
CVS
39
-11
CNP
52
2
CHD
37
2
USB
64
-2
MNST
51
2
DVA
52
-2
STZ
55
-2
CMCSA
42
8
MSFT
40
-3
HRB
41
3
OXY
38
-2
DTE
38
-2
IVZ
68
-5
GD
57
-6
MDLZ
22
-16
CA
21
-6
NTRS
64
-3
HIG
56
-2
AA
67
-5
FSLR
55
-11
CVS
39
-11
CNP
52
2
CHD
37
2
USB
64
-2
MNST
51
2
DVA
52
-2
STZ
55
-2
CMCSA
42
8
Financhill
Back

Crombie Real Estate Investment Trust Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
17

CRR.UN.TO
Crombie Real Estate Investment Trust

Last Price:
$15.26
Seasonality Move:
0.77%
Buy
67

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$113.86
Seasonality Move:
-9.01%
Sell
17
Crombie Real Estate Investment Trust (CRR.UN.TO) is a Sell

Is Crombie Real Estate Investment Trust a Buy, Sell or Hold?

  • The current Crombie Real Estate Investment Trust [CRR.UN.TO] share price is $15.15. The Score for CRR.UN.TO is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • CRR.UN.TO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
67
Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CRR.UN.TO Stock Price Chart

What is Crombie Real Estate Investment Trust's stock price today?

  • The Crombie Real Estate Investment Trust share price today is $15.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRR.UN.TO is experiencing slight buying pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $113.56
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

CRR.UN.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 49.03 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.1 - 15.36) Sell
Bollinger Bands (100): (14.81 - 15.29) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.67 Buy
Relative Strength Index (14 RSI): 59.45 Buy
Chaikin Money Flow: -357754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (98.81 - 108.61) Buy
Bollinger Bands (100): (93.91 - 107.83) Buy

CRR.UN.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.09 Buy
20-day SMA: 15.23 Sell
50-day SMA: 15.18 Sell
200-day SMA: 14.79 Buy
8-day EMA: 15.13 Buy
20-day EMA: 15.17 Sell
50-day EMA: 14.82 Buy
200-day EMA: 9.26 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 107.1 Buy
20-day SMA: 105.06 Buy
50-day SMA: 105.14 Buy
200-day SMA: 81.74 Buy
8-day EMA: 108.55 Buy
20-day EMA: 106.16 Buy
50-day EMA: 103.93 Buy
200-day EMA: 86.65 Buy

Crombie Real Estate Investment Trust Earnings Growth & CRR.UN.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.01 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Crombie Real Estate Investment Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):